<br>混合生物矿化纳米囊泡可增强发炎肺部的生物分布并减少糖皮质激素治疗 ARDS 的副作用,Journal of Controlled Release

当前位置： X-MOL 学术 › J. Control. Release › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

混合生物矿化纳米囊泡可增强发炎肺部的生物分布并减少糖皮质激素治疗 ARDS 的副作用
Journal of Controlled Release ( IF 10.5 ) Pub Date : 2024-04-15 , DOI: 10.1016/j.jconrel.2024.04.015
Qi Qiao ₁ , Xiaonan Li ₂ , Xiangjun Ou ₂ , Xiong Liu ₂ , Chuansheng Fu ₂ , Yi Wang ₂ , Boning Niu ₂ , Li Kong ₂ , Conglian Yang ₂ , Zhiping Zhang ₃

Affiliation

急性呼吸窘迫综合征（ARDS）是一种以严重肺部炎症为特征的危重疾病。提高递送效率并实现抗炎药物在肺部炎症部位的控释是ARDS治疗的主要挑战。利用增加的肺血管通透性和微酸性炎症微环境，构建了基于地塞米松磷酸钠（DSP）和Ca的pH响应性矿化纳米颗粒。通过对 M2 巨噬细胞膜进行进一步仿生修饰，混合矿化纳米囊泡 (MM@LCaP) 被设计为具有膜的免疫调节能力，并保留核心纳米颗粒的 pH 敏感性，以便在酸性炎症条件下响应药物释放。与健康小鼠相比，静脉注射后48小时，炎症小鼠体内MM@LCaP的肺/肝蓄积量增加了约5.5倍。 MM@LCaP 促进抗炎巨噬细胞的极化，镇静炎症细胞因子，并表现出全面的治疗效果。此外，MM@LCaP 改善了糖皮质激素的安全性。综上所述，基于混合矿化纳米囊泡的药物递送策略可能为提高临床药物的疗效和降低毒性提供有前景的想法。

"点击查看英文标题和摘要"

Hybrid biomineralized nanovesicles to enhance inflamed lung biodistribution and reduce side effect of glucocorticoid for ARDS therapy

Acute respiratory distress syndrome (ARDS) is a critical illness characterized by severe lung inflammation. Improving the delivery efficiency and achieving the controlled release of anti-inflammatory drugs at the lung inflammatory site are major challenges in ARDS therapy. Taking advantage of the increased pulmonary vascular permeability and a slightly acidic-inflammatory microenvironment, pH-responsive mineralized nanoparticles based on dexamethasone sodium phosphate (DSP) and Ca were constructed. By further biomimetic modification with M2 macrophage membranes, hybrid mineralized nanovesicles (MM@LCaP) were designed to possess immunomodulatory ability from the membranes and preserve the pH-sensitivity from core nanoparticles for responsive drug release under acidic inflammatory conditions. Compared with healthy mice, the lung/liver accumulation of MM@LCaP in inflammatory mice was increased by around 5.5 times at 48 h after intravenous injection. MM@LCaP promoted the polarization of anti-inflammatory macrophages, calmed inflammatory cytokines, and exhibited a comprehensive therapeutic outcome. Moreover, MM@LCaP improved the safety profile of glucocorticoids. Taken together, the hybrid mineralized nanovesicles-based drug delivery strategy may offer promising ideas for enhancing the efficacy and reducing the toxicity of clinical drugs.

更新日期：2024-04-15

点击分享查看原文

点击收藏

阅读更多本刊新发论文本刊介绍/投稿指南